Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: An evidence-based meta-analysis

Ophthalmology

Volumn 117, Issue 7, 2010, Pages

  Bachmann, Bjorn ^a   Taylor, Rod S ^b   Cursiefen, Claus ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CORNEA NEOVASCULARIZATION; EVIDENCE BASED PRACTICE; GRAFT FAILURE; GRAFT REJECTION; HUMAN; KERATOPLASTY; LYMPH VESSEL; META ANALYSIS; PRIORITY JOURNAL; REMISSION; RISK FACTOR; SYSTEMATIC REVIEW;

ADULT; AGED; CORNEAL NEOVASCULARIZATION; DATABASES, FACTUAL; FEMALE; GRAFT REJECTION; HUMANS; KERATOPLASTY, PENETRATING; MALE; MIDDLE AGED; ODDS RATIO; REGISTRIES; RISK FACTORS;

EID: 77954349323     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2010.01.039     Document Type: Article

References (40)

1. K.A. Williams, M.T. Lowe, and C.M. Bartlett The Australian Corneal Graft Registry 2007 Report 2007 Flinders University Press Adelaide, Australia 69 70 http://dspace.flinders.edu.au/dspace/handle/2328/1723 Accessed September 11, 2009
2. Collaborative Corneal Transplantation Studies Research Group The Collaborative Corneal Transplantation Studies (CCTS): effectiveness of histocompatibility matching in high-risk corneal transplantation Arch Ophthalmol 110 1992 1392 1403
3. C. Cursiefen, J. Cao, and L. Chen Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival Invest Ophthalmol Vis Sci 45 2004 2666 2673
4. V.M. Lam, N.X. Nguyen, and P. Martus Surgery-related factors influencing corneal neovascularization after low-risk keratoplasty Am J Ophthalmol 141 2006 260 266
5. T. Dietrich, J. Onderka, and F. Bock Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade Am J Pathol 171 2007 361 372
6. H. Kubo, R. Cao, and E. Brakenhielm Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea Proc Natl Acad Sci U S A 99 2002 8868 8873
7. F. Bock, J. Onderka, and T. Dietrich Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation Graefes Arch Clin Exp Ophthalmol 246 2008 115 119
8. Y. Jin, L. Shen, and E.M. Chong The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking Mol Vis [serial online] 13 2007 626 634 http://www.molvis.org/molvis/v13/a68/ Accessed December 23, 2009
9. J.P. Higgins, and S. Green Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2. Part 2: General methods for Cochrane reviews www.cochrane-handbook.org Accessed January 17, 2010
10. K.R. Johnson, C. Ringland, and B.J. Stokes Response rate or time to progression as predictors of survival in trials of metastatic colorectal cancer or non-small-cell lung cancer: a meta-analysis Lancet Oncol 7 2006 741 746
11. W. Ichikawa, and Y. Sasaki Correlation between tumor response to first-line chemotherapy and prognosis in advanced gastric cancer patients Ann Oncol 17 2006 1665 1672
12. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
13. R.S. Taylor, J.P. Van Buyten, and E. Buchser Spinal cord stimulation for chronic back and leg pain and failed back surgery syndrome: a systematic review and analysis of prognostic factors Spine (Phila Pa 1976) 30 2005 152 160
14. A. Vail, S.M. Gore, B.A. Bradley Collaborating Surgeons Conclusions of the Corneal Transplant Follow up Study Br J Ophthalmol 81 1997 631 636
15. D.T. Tan, P. Janardhanan, and H. Zhou Penetrating keratoplasty in Asian eyes: the Singapore Corneal Transplant Study Ophthalmology 115 2008 975 982
16. J. Higgins, S. Thompson, J. Deeks, and D. Altman Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice J Health Serv Res Policy 7 2002 51 61
17. B.O. Bachmann, F. Bock, and S.J. Wiegand Promotion of graft survival by vascular endothelial growth factor A neutralization after high-risk corneal transplantation Arch Ophthalmol 126 2008 71 77
18. B.O. Bachmann, E. Luetjen-Drecoll, and F. Bock Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation Br J Ophthalmol 93 2009 1075 1080
19. C. Cursiefen, U. Schlotzer-Schrehardt, and M. Kuchle Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin Invest Ophthalmol Vis Sci 43 2002 2127 2135
20. F. Bock, Y. Konig, and F. Kruse Bevacizumab (Avastin) eye drops inhibit corneal neovascularization Graefes Arch Clin Exp Ophthalmol 246 2008 281 284
21. F. Bock, J. Onderka, and T. Dietrich Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis Invest Ophthalmol Vis Sci 48 2007 2545 2552
22. S.W. Kim, B.J. Ha, and E.K. Kim The effect of topical bevacizumab on corneal neovascularization [online report] Ophthalmology 115 2008 e33 e38 http://www.ophsource.org/periodicals/ophtha/article/S0161-6420%2808%2900176-0/ abstract Accessed December 23, 2009
23. C. Cursiefen, F. Bock, and F.K. Horn GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial Ophthalmology 116 2009 1630 1637
24. O.C. Alldredge, and J.H. Krachmer Clinical types of corneal transplant rejection: their manifestations, frequency, preoperative correlates, and treatment Arch Ophthalmol 99 1981 599 604
25. V.L. Bishop, L.P. Robinson, A.W. Wechsler, and F.A. Billson Corneal graft survival: a retrospective Australian study Aust N Z J Ophthalmol 14 1986 133 138
26. H.M. Boisjoly, R. Tourigny, and R. Bazin Risk factors of corneal graft failure Ophthalmology 100 1993 1728 1735
27. L. Dandona, T.J. Naduvilath, and M. Janarthanan Survival analysis and visual outcome in a large series of corneal transplants in India Br J Ophthalmol 81 1997 726 731
28. J.C. Hill The relative importance of risk factors used to define high-risk keratoplasty Ger J Ophthalmol 5 1996 36 41
29. T. Hoppeler, R. Ganzfried, and B. Gloor The fate of corneal transplants from the Zurich eye bank [in German] Klin Monbl Augenheilkd 200 1992 388 391
30. K. Inoue, S. Amano, T. Oshika, and T. Tsuru Risk factors for corneal graft failure and rejection in penetrating keratoplasty Acta Ophthalmol Scand 79 2001 251 255 (Pubitemid 32577308)
31. M.J. Jager, L.J. Hermans, and C.L. Dake Follow-up of corneal transplantations at the Academic Medical Center of Amsterdam Doc Ophthalmol 70 1988 137 144
32. J.B. Jonas, R.M. Rank, and W.M. Budde Immunologic graft reactions after allogenic penetrating keratoplasty Am J Ophthalmol 133 2002 437 443
33. M.G. Maguire, W.J. Stark, J.D. Gottsch Collaborative Corneal Transplantation Studies Research Group Risk factors for corneal graft failure and rejection in the Collaborative Corneal Transplantation Studies Ophthalmology 101 1994 1536 1547
34. M.O. Price, R.W. Thompson Jr, and F.W. Price Jr Risk factors for various causes of failure in initial corneal grafts Arch Ophthalmol 121 2003 1087 1092
35. D. Sellami, S. Abid, and G. Bouaouaja Epidemiology and risk factors for corneal graft rejection Transplant Proc 39 2007 2609 2611
36. R. Tachihara, E. Uchio, and M. Sugita Multivariate analysis of factors affecting immunological rejection after penetrating keratoplasty Rinsho Ganka 54 2000 1221 1224
37. H.J. Volker-Dieben, and J.Kok-van Alphen C.C. D'Amaro Hierarchy of prognostic factors for corneal allograft survival Aust N Z J Ophthalmol 15 1987 11 18
38. K.A. Williams, A.J. Esterman, and C. Bartlett How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis Transplantation 81 2006 896 901
39. S. Yamagami, M.R. Dana, and T. Tsuru Draining lymph nodes play an essential role in alloimmunity generated in response to high-risk corneal transplantation Cornea 21 2002 405 409
40. O. Yano, and K. Okubo The factors necessary to achieve successful penetrating keratoplasty [in Japanese] J UOEH 9 1987 249 253